Completed from United Kingdom
Just finished the Advanced Pharmacoeconomics course and I’m impressed. It helped me nail down the basics of health‑technology assessment, which was my main learning goal. The practical sessions on Markov modelling were spot‑on – I can now build a simple model from scratch without any hassle. The PDFs and video lectures were clear and up‑to‑date, though a few more interactive quizzes would’ve been nice. All in all, a solid programme that gave me useful skills for my job at a NHS consultancy.
The Advanced Pharmacoeconomics Certificate exceeded my expectations. The curriculum was perfectly aligned with my goal to lead cost‑effectiveness analyses in my hospital. I especially appreciated the module on budget impact modelling, which gave me a step‑by‑step Excel template I now use weekly. The case studies featuring real‑world drug pricing scenarios were highly relevant, and the instructor’s feedback on my assignments was prompt and insightful. Overall, the course material was top‑notch and the learning platform was easy to navigate, making the entire experience both rigorous and enjoyable.
Wow! This course was absolutely fantastic! I wanted to understand how to evaluate the economic value of new medicines, and the instructors broke down complex concepts into bite‑size, actionable insights. The hands‑on workshop on incremental cost‑effectiveness ratio (ICER) calculations was a game‑changer – I applied it to a real case on oncology drugs and impressed my senior manager. The study materials were vibrant, with plenty of charts and real‑world examples from emerging markets. I left the course feeling confident, motivated, and ready to drive value‑based decisions in my organization.
I approached the Advanced Pharmacoeconomics Certificate with a clear objective: to acquire the analytical tools necessary for pricing negotiations in the South African pharmaceutical sector. The programme delivered on that promise through a meticulously structured syllabus. The segment on sensitivity analysis taught me how to test the robustness of cost‑utility models, which I immediately applied to a pricing proposal for a generic antiretroviral. The course pack included comprehensive reading lists, up‑to‑date WHO guidelines, and downloadable R scripts that facilitated hands‑on practice. While the pacing was intensive, the depth of content and the instructor’s expertise made the learning experience highly rewarding.
